{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:29:10Z","timestamp":1791401350440,"version":"4.3.3"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:00:00Z","timestamp":1307404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001153","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T15:44:25Z","timestamp":1308325465000},"page":"e1153","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":150,"title":["Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review"],"prefix":"10.1371","volume":"5","author":[{"given":"Gl\u00e1ucia F.","family":"Cota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/000349803225002499","article-title":"Leishmania\/HIV co-infections: epidemiology in Europe.","volume":"97","author":"P Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref2","article-title":"Leishmania\/HIV co-infection, South Western Europe 1990\u201398","author":"P Desjeux","year":"2000"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1998.58.436","article-title":"Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.","volume":"58","author":"R Lopez-Velez","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002030-199606001-00014","article-title":"Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy.","volume":"10","author":"L Gradoni","year":"1996","journal-title":"AIDS (London, England)"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years.","volume":"21","author":"J Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref6","first-page":"197","article-title":"Pre- &amp; post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.","volume":"123","author":"PK Sinha","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1179\/000349803225002561","article-title":"The pathogenesis of Leishmania\/HIV co-infection: cellular and immunological mechanisms.","volume":"97","author":"M Olivier","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0169-4758(96)10021-1","article-title":"Leishmania and the pathogenesis of HIV infection.","volume":"12","author":"M Tremblay","year":"1996","journal-title":"Parasitol Today"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s100960000364","article-title":"Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy.","volume":"19","author":"JL Villanueva","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/dkm294","article-title":"Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.","volume":"60","author":"I Molina","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1097\/00002030-200012220-00020","article-title":"Discontinuation of secondary anti-<italic>Leishmania<\/italic> prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.","volume":"14","author":"J Berenguer","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s100960100457","article-title":"Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.","volume":"20","author":"JL Casado","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0022-3859.929","article-title":"Leishmaniasis in HIV infection.","volume":"49","author":"R Paredes","year":"2003","journal-title":"J Postgrad Med"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis.","volume":"6","author":"S Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/000349803225002507","article-title":"Leishmania\/HIV co-infection in Brazil: an appraisal.","volume":"97","author":"A Rabello","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"ref16","article-title":"Leishmaniasis: background information. A brief history of the disease.","year":"2009"},{"issue":"1","key":"ref17","first-page":"152","article-title":"Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.","volume":"13","author":"MJ Jimenez-Exposito","year":"1999","journal-title":"AIDS (London, England)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"A Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1741-7015-2-23","article-title":"Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey.","volume":"2","author":"NL Wilczynski","year":"2004","journal-title":"BMC Med"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.36076\/ppj.2009\/12\/819","article-title":"Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.","volume":"12","author":"L Manchikanti","year":"2009","journal-title":"Pain Physician"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jclinepi.2010.04.013","article-title":"The Catch-22 of appraisals on the quality of observational studies.","volume":"63","author":"RH Groenwold","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"ref22","first-page":"559","article-title":"STROBE initiative: guidelines on reporting observational studies.","volume":"44","author":"M Malta","year":"2010","journal-title":"Rev Saude Publica"},{"issue":"35","key":"ref23","first-page":"1658","article-title":"Visceral leishmaniasis in HIV infection. A totally opportunistic infection.","volume":"21","author":"A Cabie","year":"1992","journal-title":"Presse Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/qjmed\/77.2.1101","article-title":"Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.","volume":"77","author":"BS Peters","year":"1990","journal-title":"Q J Med"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00002030-199102000-00011","article-title":"Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.","volume":"5","author":"J Altes","year":"1991","journal-title":"AIDS (London, England)"},{"issue":"2","key":"ref26","first-page":"75","article-title":"Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.","volume":"87","author":"RN Davidson","year":"1994","journal-title":"Q J Med"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/clinids\/19.3.560","article-title":"Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.","volume":"19","author":"RN Davidson","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0035-9203(95)90476-X","article-title":"Visceral leishmaniasis and HIV-1 co-infection in southern France.","volume":"89","author":"E Rosenthal","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"ref29","first-page":"301","article-title":"Visceral leishmaniasis in immunocompromised patients.","volume":"15","author":"A Ramos","year":"1998","journal-title":"An Med Interna"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1198-743x.2001.00262.x","article-title":"HIV-associated visceral leishmaniasis.","volume":"7","author":"V Pintado","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02767767","article-title":"Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases.","volume":"26","author":"C Agostoni","year":"1998","journal-title":"Infection"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus.","volume":"96","author":"I Cruz","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.actatropica.2006.08.002","article-title":"Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.","volume":"99","author":"G d'Ettorre","year":"2006","journal-title":"Acta Trop"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1645\/GE-1678.1","article-title":"Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.","volume":"95","author":"EF Daher","year":"2009","journal-title":"J Parasitol"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.","volume":"15","author":"Z Hurissa","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","article-title":"Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.","volume":"44","author":"S Antinori","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2003.09.009","article-title":"Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis.","volume":"90","author":"ML Fernandez-Guerrero","year":"2004","journal-title":"Acta Trop"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1179\/000349803225002624","article-title":"Clinical survey of Leishmania\/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART).","volume":"97","author":"R Russo","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.","volume":"95","author":"K Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/JCM.38.1.236-240.2000","article-title":"Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.","volume":"38","author":"L Lachaud","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00126334-200207010-00015","article-title":"Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.","volume":"30","author":"C Tortajada","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"ref42","first-page":"73","article-title":"[Visceral leishmaniasis in patients with HIV infection].","volume":"13","author":"E Ribera","year":"1995","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"12","key":"ref43","first-page":"899","article-title":"Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up.","volume":"23","author":"C Riera","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4269\/ajtmh.2005.73.1012","article-title":"Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with <italic>Leishmania<\/italic> and human immunodeficiency virus.","volume":"73","author":"C Riera","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/505217","article-title":"A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.","volume":"43","author":"K Ritmeijer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0002-9343(97)89503-4","article-title":"Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.","volume":"100","author":"E Ribera","year":"1996","journal-title":"Am J Med"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.","volume":"46","author":"R ter Horst","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"RR-17","key":"ref48","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","journal-title":"MMWR Recomm Rep1992"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAI.0b013e318166af5d","article-title":"Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis.","volume":"48","author":"N Bourgeois","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005792-200101000-00006","article-title":"Visceral leishmaniasis in HIV-infected and non-HIV-infected patients: a comparative study.","volume":"80","author":"VM-RP Pintado","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.39.1.357-361.2001","article-title":"Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.","volume":"39","author":"M Pizzuto","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10096-005-1342-6","article-title":"Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterranean region.","volume":"24","author":"F Pasquau","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF01700556","article-title":"Visceral leishmaniasis in patients infected with the human immunodeficiency virus.","volume":"16","author":"F Laguna","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1086\/377607","article-title":"Effect of highly active antiretroviral therapy on the incidence and clinical manifestations of visceral leishmaniasis in human immunodeficiency virus-infected patients.","volume":"37","author":"MJ Fernand\u00e9z Cotarelo","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.41.11.5080-5084.2003","article-title":"Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.","volume":"41","author":"S Bossolasco","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkh084","article-title":"Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.","volume":"53","author":"R L\u00f3pez-V\u00e9lez","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"ref57","first-page":"506","article-title":"[The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].","volume":"14","author":"M Delgado Fernand\u00e9z","year":"1997","journal-title":"An Med Interna"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4269\/ajtmh.2004.70.298","article-title":"Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.","volume":"70","author":"JA Mira","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref59","first-page":"289","article-title":"Visceral leishmaniasis in the New World &amp; Africa.","volume":"123","author":"J Berman","year":"2006","journal-title":"Indian J Med Res"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/IAI.69.2.1212-1214.2001","article-title":"T cells that react to the immunodominant <italic>Leishmania<\/italic> major LACK antigen prevent early dissemination of the parasite in susceptible BALB\/c mice.","volume":"69","author":"S Schilling","year":"2001","journal-title":"Infect Immun"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0031182002002081","article-title":"Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers.","volume":"125","author":"L Lachaud","year":"2002","journal-title":"Parasitology"},{"issue":"7","key":"ref62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1198-743x.2001.00270.x","article-title":"Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART).","volume":"7","author":"R L\u00f3pez-V\u00e9lez","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human <italic>Leishmania<\/italic> donovani infections.","volume":"71","author":"M Kemp","year":"1993","journal-title":"Immunol Cell Biol"},{"issue":"9","key":"ref64","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.4049\/jimmunol.143.9.3020","article-title":"IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma.","volume":"143","author":"M Lehn","year":"1989","journal-title":"J Immunol"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1365-2249.1999.00927.x","article-title":"Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART+IL-2.","volume":"116","author":"S Zanussi","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/00002030-199907090-00006","article-title":"Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.","volume":"13","author":"I Mezzaroma","year":"1999","journal-title":"AIDS (London, England)"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.","volume":"30","author":"JE Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref68","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1086\/344325","article-title":"Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.","volume":"186","author":"P del Giudice","year":"2002","journal-title":"J Infect Dis"},{"issue":"13","key":"ref69","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"FJ Palella Jr","year":"1998","journal-title":"N Engl J Med"},{"key":"ref70","first-page":"407","article-title":"Diagnosis &amp; management of <italic>Leishmania\/<\/italic>HIV co-infection.","volume":"121","author":"PK Sinha","year":"2005","journal-title":"Indian J Med Res"},{"issue":"4","key":"ref71","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"14","author":"V Soriano","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"14","key":"ref72","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","article-title":"HIV viral load and response to antileishmanial chemotherapy in co-infected patients.","volume":"13","author":"N Berhe","year":"1999","journal-title":"AIDS (London, England)"},{"issue":"9","key":"ref73","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-<italic>Leishmania<\/italic> Study Group.","volume":"13","author":"F Laguna","year":"1999","journal-title":"AIDS (London, England)"},{"issue":"4","key":"ref74","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of <italic>Leishmania infantum<\/italic> to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.","volume":"41","author":"F Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/jac\/47.1.120","article-title":"In vitro susceptibility of <italic>Leishmania infantum<\/italic> to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients.","volume":"47","author":"J Carrio","year":"2001","journal-title":"J Antimicrob Chemother"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:33:37Z","timestamp":1686126817000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001153"}},"subtitle":[],"editor":[{"given":"Charles L.","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,7]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001153","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,7]]}}}